Universität Regensburg

University / College


Location: Regensburg, Germany (DE) DE

ISNI: 0000000121905763

ROR: https://ror.org/01eezs655

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cerebral lesion correlates of sympathetic cardiovascular activation in multiple sclerosis (2019) Winder K, Linker RA, Seifert F, Wang R, Lee DH, Engelhorn T, Dörfler A, et al. Journal article Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry (2019) Götz TI, Schmidkonz C, Lang EW, Maier A, Kuwert T, Ritt P Journal article Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry (2019) Apfelbacher CJ, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, Heinrich A, et al. Journal article A Nonagonal Framework of Regulation in Talent Development (NFRTD) (2019) Ziegler A, Stoeger H Journal article Deep brain stimulation: Connectivity profile for bradykinesia alleviation (2019) Strotzer QD, Anthofer JM, Faltermeier R, Brawanski AT, Torka E, Waldthaler JA, Kohl Z, et al. Journal article Concept paper on the technique of cryopreservation, removal and transplantation of ovarian tissue for fertility preservation (2019) Beckmann M, Lotz L, Toth B, Baston-Buest DM, Fehm T, Frambach T, Germeyer A, et al. Journal article Metal‐Assisted Opening of Intact P4 Tetrahedra (2019) Modl M, Heinl S, Balázs G, Delgado Calvo F, Caporali M, Manca G, Keilwerth M, et al. Journal article HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting (2019) Neubert P, Weichselbaum A, Reitinger C, Schatz V, Schröder A, Ferdinand JR, Simon M, et al. Journal article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (2019) Breyer J, Wirtz RM, Erben P, Rinaldetti S, Worst TS, Stoehr R, Eckstein M, et al. Journal article